Successful rechallenge with cetuximab after an infusion related reaction to panitumumab in a patient with locally advanced rectal cancer

Incidence of infusion related reaction (IR) is more common with cetuximab (Cmab) than with panitumumab (Pmab). Although little is known about rechallenge IR with monoclonal antibodies, we experienced a successful rechallenge to Cmab after IR to Pmab. A 67-year-old female patient was scheduled for ch...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int Cancer Conf J
Main Authors: Yokokawa, Hideyuki, Kono, Teppei, Shidei, Hiroaki, Oyama, Kunihiro, Ito, Yoshitomo, Imaizumi, Rie, Miyano, Yutaka, Shiozawa, Shunichi, Yoshimatsu, Kazuhiko
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Singapore 2020
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7797389/
https://ncbi.nlm.nih.gov/pubmed/33489709
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13691-020-00455-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados